Astellas Pharma(MX:4503N)
MX$255.940.00 (0.00%)
MX:4503N
Astellas Pharma earnings date
MX$255.94
At close:0.00 (0.00%)
Astellas Pharma (4503N) Q1 2026 Earnings Report
1 Followers
MX:4503N Q1 2026 EPS Results
- Actual EPS
- MXN 9.39
- Consensus EPS
- MXN 6.42
- Beat/Miss
- Beat by +MXN 2.97
- One Year Ago EPS
- MXN 4.53
MX:4503N Q1 2026 Revenue Results
- Actual Revenue
- MXN 76.03B
- Expected Revenue
- MXN 66.37B
- Beat/Miss
- Beat by +MXN 9.65B
- YoY Revenue Growth
- +26.71%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 08/05/2026
- Time
- Before Open
- Conference Call
- Wednesday, August 5, 2026
MX:4503N Upcoming Earnings
Astellas Pharma's next earnings date is estimated for February 8, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
MX:4503N Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4503N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 08, 2027 | 2026 (Q3) | 7.11- | 6.65 | ― | ― |
| Nov 04, 2026 | 2026 (Q2) | 7.716.60 | 5.25 | 25.92% (+1.36) | |
| Aug 05, 2026 | 2026 (Q1) | 6.429.39 | 4.53 | 107.09% (+4.86) | |
| Apr 27, 2026 | 2025 (Q4) | 3.632.88 | 4.96 | -41.95% (-2.08) | |
| Feb 04, 2026 | 2025 (Q3) | 5.456.65 | -6.47 | 202.73% (+13.12) | |
| Oct 30, 2025 | 2025 (Q2) | 3.545.25 | 2.38 | 120.44% (+2.87) | |
| Jul 30, 2025 | 2025 (Q1) | 2.364.53 | 2.49 | 82.00% (+2.04) | |
| Apr 25, 2025 | 2024 (Q4) | 2.534.96 | -2.2 | 325.50% (+7.16) | |
| Feb 04, 2025 | 2024 (Q3) | 2.91-6.47 | 1.23 | -624.52% (-7.70) | |
| Oct 30, 2024 | 2024 (Q2) | 2.142.38 | -0.09 | 2607.50% (+2.47) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
